his report is a concise review of current knowledge of the structure and function of the intima of the aorta and the major distributing arteries. The main purpose of the review is to delineate normal arterial intima from atherosclerotic lesions and, in particular, to distinguish physiological adaptations from atherosclerotic increases in intimal thickness. To characterize normal intima, including the adaptive intimal thickenings, some of which represent locations in which atherosclerotic lesions are prone to develop, the structure, composition, and functions of the arterial intima in young people as well as in laboratory animals not subjected to known atherogenic stimuli are reviewed.
of tissue sampling and preparation are responsible for some discrepancies among the many studies. Artifacts of technique may be acceptable and discrepancies reconciled if the associated changes are recognized, evaluated, compensated, and standardized.
For example, when dimensions and structure of arterial intima and atherosclerotic lesions are to be assessed, fixation of vessels while distended at mean arterial pressure is essential to approximate as closely as possible, and under standard conditions, the in vivo state. Configurational distortions and tissue disruptions associated with collapse and retraction of an artery or with improper tissue handling have been misinterpreted as abnormalities in many studies. Some of the artifacts have been reported in the literature as lesions. Focal physiological adaptations in intimal thickness have, for example, been thought to represent arterial stenoses or occlusions because of protrusion of the intima into the lumen when arteries were studied in the collapsed and contracted state ( Figure 1 ). When elastic arteries are released and removed from their supporting tissues, they contract by about one third.
Because intimal structure is in part related to arterial geometry, samples for study should be obtained in a standardized manner that is reproducible and representative. The sampling should have a defined and consistent relation to anatomic landmarks such as the origins of specific branch vessels. However, the size of the samples taken for study should not be too small to be representative, for small shifts in vessel geometry with respect to branches and with regard to circumference influence both the extent and location of adaptations of the intima. Standardization of quantitative techniques for evaluating tissues is especially important with regard to the current development of automatic or semiautomatic measuring devices. For example, it is essential that adequate methodological details are 122 Arteriosclerosis and Thrombosis Vol 12, No 1 January 1992 type deteriorate especially rapidly after death. Such considerations must be taken into account in interpretations of studies on the ultrastructural and molecular level.
Definition of Arterial Intima
The intima is defined as the region of the arterial wall from and including the endothelial surface at the lumen to the luminal margin of the media. The internal elastic lamina, generally considered part of the media, denotes the border between intima and media. However, a well-defined internal elastic lamina is absent in some parts of geometric transitions of arteries such as bifurcations, branch vessels, and curvatures. Thus, in these regions, recognition of the demarcation between intima and media may be difficult.
The thickness of arterial intima is not uniform. The criteria for normal thickness should recognize a broad range conveniently expressed quantitatively as the intima:media ratio. The ratio may vary from about 0.1 to 1.0 or more in normal arteries of humans. 1 Thick segments of intima exist in arteries obtained from healthy human subjects of all ages and from many other species. The thick segments may be focal (eccentric) or they may be more extensive (diffuse). They represent physiological adaptations to changes in flow and wall tension.
At vascular transitions such as bifurcations or trifurcations, normal structural reorganizations of the arterial wall, themselves localized thickenings, may overlap or fuse with intimal thickening caused by physiological adaptation. Structural reorganizations involve thickening of the deep (musculoelastic) intima layer and of the adjacent inner media. In regions of vascular transitions, the internal elastic lamina is partly or completely absent, and the intima and media may appear as a unit, indistinguishable from each other. Although it is sometimes difficult to distinguish how much of a particular thickening is intima or media and how much is of the adaptive or reorganizational type, the structures are composed of normal elements, differing clearly from atherosclerotic changes and other conditions. The difference between normal and pathological structure is clear when vessels are studied with appropriate methods.
The arterial intima is composed of two layers ( Figure 2 ). The layers may be absent or barely visible by light microscopy in segments of arteries with a very thin intima. In segments with adaptive thickening of the eccentric or diffuse type, the layers are clearly visible. The inner layer, subjacent to the lumen, has been called the proteogtycan layer because it contains an abundance of finely reticulated nonfibrous connective tissue identified as proteoglycan ground substance by electron microscopy. The thicker layer underlying the proteoglycan layer (and adjacent to the media) has been called the musculoelastic layer because of the abundance of smooth muscle cells and elastic fibers. This lower intima layer also contains more collagen than the upper layer. Smooth muscle cells are of the myofilament-rich phenotype and arranged in close layers.
The individual cell and matrix components are reviewed in more detail under separate headings in subsequent sections of this report.
Physiological Adaptations in Intimal Thickness: Eccentric and Diffuse Intimal Thickening Definition of Adaptive Intimal Thickening
The regions of thick but undiseased intima discussed here represent physiological adaptations to mechanical stresses secondary to variations in flow, wall tension, or both. Some authors have used the terms eccentric and diffuse to differentiate between two patterns of adaptive intimal thickening, although the two are generally contiguous, run into one another, and sometimes cannot be clearly distinguished from each other.
Eccentric intimal thickening is a relatively abrupt and focal increase in the thickness of the intima associated with branches and orifices. At an arterial bifurcation, the thickening involves about half the circumference (i.e., the outer wall, that opposite the flow divider) of the parent and daughter vessels and extends for a short distance along the length of the artery proximal and distal to the flow divider. In arteries fixed under physiological pressure, the structure is a crescent-shaped increase in intimal thickness (Figure 2 ). Eccentric thickening has been seen in coronary, carotid, cerebral, and renal arteries, although the extent and thickness were not described precisely in some arteries. In human coronary arteries, eccentric thickening has been observed from the first week of life and thereafter, although considerable individual variation in degree is found.
1 Its three-dimensional extent has been graphically outlined. 4 Diffuse intimal thickening is a spread-out and often circumferential pattern of adaptive intimal thickening not clearly related to specific geometric configurations of arteries. In coronary arteries the degree of thickening is less than that of eccentric thickening, although more extensive.
There are only incomplete data on the range of eccentric and diffuse intimal thickening in arteries. What is known is based on the study of sample regions of vessels. The eccentric variant has been relatively well mapped in some arteries, but the extent of diffuse thickening and its relation to anatomic landmarks in vessels is not clear. In humans, adaptive intimal thickening of one or the other pattern may involve much of 
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the extent of some arteries. More information could be acquired through microscopic studies; however, an inordinate number of microscopic sections would be required to map, for example, the intima of the human aorta precisely. Variation between persons and possible changes with age complicate the mapping.
Adaptive increases in intimal thickness do not obstruct the vascular lumen, although they may appear to do so in improperly fixed vessels (see "Role of Laboratory Technique in Evaluation of the Arterial Intima" and Figure 1 ). In particular, adaptive thickenings of the eccentric pattern appear as localized bulges into the lumen in arteries that were allowed to collapse and contract. Some adaptive intimal thickenings coincide with locations at which advanced atherosclerotic lesions develop early (atherosclerosis-prone locations). The relation between adaptive intimal thickening and atherosclerosis is discussed in a subsequent section of this report. Adaptive thickening can be clearly recognized by light microscopy of sections 1 /xm thick. The microscopic composition is that of arterial intima in general (described in "Definition of Arterial Intima"), except for proportional increases in thickness. In thickenings of the eccentric pattern, the two normal layers of the intima are distinct and prominent.
Regions of the intima with adaptive increases in thickness differ functionally from adjacent, thinner regions. The turnover of endothelial cells 5 and smooth muscle cells 6 Intimal thickening lacking the features of atherosclerosis or other disease processes was described in the human aorta in 1883 by Thoma, 14 who assumed it to be a universal feature in human arterial development. 15 In the early 1920s, Wolkoff 1617 
Hemodynamic Causes of Adaptive Intimal Thickening
Adaptive intimal thickening may be thought of as the consequence of a range of physiological stimuli, constituting an attempt by the tissue to maintain normal conditions of flow, wall tension, or both. Intima, as a living, reactive tissue, adapts in thickness to changes in pulse rate, blood pressure, arterial geometry, flow rate, and resistance to flow in distal vascular segments and in supplied organs.
Arterial locations with eccentric and diffuse intimal thickening correspond to regions of altered mechanical stress. 4647 In these locations, wall shear stress is reduced or wall tensile stress is elevated, or both. These findings indicate that the intima may thicken in response to reduced wall shear, reducing lumen diameter to elevate flow velocity and thereby restore wall shear to baseline values. 42 In response to increased tensile stress, intimal thickening would appear to strengthen the arterial wall to maintain normal values of tensile stress. Thus, the intima may participate in adaptive remodeling processes in adjusting to altered local mechanical stresses. In relatively straight arterial segments, such mechanical stresses are evenly distributed, causing diffuse thickening. The thickening would be eccentric in regions of bifurcations and branches where both shear and tensile stresses are not uniformly distributed.
Relation Between Adaptive Intimal Thickening and Atherosclerosis
When atherosclerosis develops, advanced lesions form first in some regions with adaptive intimal thickening. In humans, the topographic distribution of eccentric intimal thickening and of advanced atherosclerotic lesions is similar in the coronary arteries, 4 -that is, in locations where atherosclerosis is most severe in later life. The susceptible regions have been called the atherosclerosis-prone areas of arteries. Because of the colocalization of advanced atherosclerotic lesions with some intimal thickening (particularly with that of the eccentric pattern) and because both are more or less focal, the question of whether eccentric intimal thickening should be considered atherosclerotic has been much debated. If eccentric thickening is accepted as a physiological adaptive process, then the development of a lesion refers only to changes superimposed on it. The available evidence indicates that specific mechanical stresses, present in locations of the arterial tree with adaptive intimal thickening, cause the thickening whether high concentrations of atherogenic lipoproteins are present or not. When atherogenic lipoproteins exceed certain critical levels, the same mechanical forces may enhance lipoprotein deposition in the same regions, leading to transformation into atheromatous lesions.
Although some intimal thickenings mark regions of increased susceptibility to formation of advanced atherosclerotic lesions, the fact remains that in severely hypercholesterolemic humans and in several species of animals subjected to severe hypercholesterolemia, nearly all regions of the aorta and of many arteries may ultimately be the sites of advanced lesions. Thus, advanced lesions are not confined to regions with adaptive intimal thickenings. The latter simply mark locations where, under the influence of atherogenic stimuli, lesions form earlier and more rapidly than elsewhere, and where, therefore, symptomatic lesions tend to occur.
Gender Differences in Adaptive Intimal Thickening
Dock 19 found variation in the intimal thickness of coronary arteries of human fetuses. He described a higher degree of intimal thickening in the arteries of males than of females. Gender differences in adaptive intimal thickening were also observed by others.
27
-48 -51 -52 However, Stary 1 calculated the ratio between the cross-sectional areas of the intima and the media of coronary arteries of young children and found no difference between young male and female children in the intima:media ratio.
Ethnic Differences in Adaptive Intimal Thickening
Neufeld 53 presented the hypothesis that ethnic differences in coronary heart disease mortality were related to differences in structural changes in coronary arteries. This hypothesis was prompted by the autopsy examination of 211 infants and children up to 10 years of age who belonged to three ethnic groups: Jews of Central and East European origin (Ashkenazi), Bedouins, and Yemenite Jews. 54 The thickness of the intimal and internal muscular layers was significantly greater in Ashkenazi boys than in boys from the two other ethnic groups. The same measurements in girls yielded few differences. Intimal thickening in the coronary arteries of children has been reported to be greater in Eastern than in Western Finland.
51
- 55 The differences paralleled differences in coronary heart disease incidence and mortality between West and East Finland. Daoud et al, 5 * who compared intimal thickening (referred to as preatheromatous proliferative changes) in the coronary arteries of young men from New York with those in young men from East Africa, found less intimal thickening and less atherosclerosis in the East Africans.
The Cells of Arterial Intima General Comments
Endothelia] cells and smooth muscle cells are the principal cellular components of human arterial intima. Isolated macrophages are also always present. These cell types are discussed in detail under separate headings.
The presence of mast cells in normal human arterial intima has been reported by several authors, 57 
"
62 but intimal mast cells are relatively rare and are not found in every person. They are particularly rare in young children, although there is electron microscopic evidence that mast cell granules may be small in young children, that mast cells may be degranulated, and that they are therefore often impossible to detect by light microscopy. 62 Therefore, mast cells may be present in arterial intima more often than present studies indicate. The possible functions of mast cells in arterial intima have been reviewed recently.
-64
Lymphocytes have been found in atherosclerotic intima, but whether they occur in normal intima is not yet clear. Jonasson et al 65 used immunocytochemistry to search for T lymphocytes in normal intima of human aortas and uterine arteries but failed to find any. However, a few T cells were found in nonatherosclerotic intima adjacent to lesions of the atheroma type in carotid arteries. Munro et al 66 did not find T lymphocytes in normal aortic intima adjacent to lesions of the fatty streak type, although the lesions contained them. Lymphocytes have been reported in the intima of nonatherosclerotic rat aortas. 67 - 68 The possible significance of lymphocytes in arterial disease has been reviewed. 69 
Endothelial Cells
Most data on endothelial cells come from animal models and in vitro experiments. Studies of endothelial cells in intact human arteries are difficult because the interval between death and study of tissues is often too long in autopsied human beings. The endothelial cells of normal muscular and elastic arteries form a continuous layer of flattened, elongated, polygonal cells. With the exception of cells situated in areas of turbulent flow and reduced shear, the long axes of endothelial cells are oriented in the direction of flow.
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and glycolipid side chains emanating from the plasma membrane. 73 Endothelial cells also synthesize and secrete extracellular matrix components, such as fibronectin, and components of the endothelial-cell basement membrane, such as type IV and type V collagen, laminin, and proteoglycans. 74 -75 The luminal surface of the plasma membrane of arterial endothelial cells contains a mosaic of microdomains, charged in part because of the distribution of anionic proteins. 76 There are also membraneassociated glycoproteins that specifically bind lectins as well as proteoglycans such as heparan sulfate proteoglycans that may be instrumental in binding lipoprotein lipase to the endothelial surface. Endothelial cells have a variable turnover rate. The thymidine labeling index for the aortic endothelium of normal mature rats is less than 1.0 (i.e., less than 1.0% of the total population of cells enter the S phase of the cell cycle in a 24-hour period), and there is a tendency for higher labeling on the dorsal than on the ventral surface of the thoracic aorta.
85 Labeling is higher around the mouths of branches originating from the aorta in guinea pigs 5 and higher in areas of Evans blue staining in pig aortas. 86 Sade et al 87 found that labeling of rat aortic endothelial cells decreased greatly with age.
Arterial endothelial cells contain a complex system of interendothelial cell junctions that include both tight and gap junctions. 88 The majority of endothelial cell-smooth muscle cell contacts are via gap junctions, where cytoplasmic bridges pass through fenestrations in the internal elastic lamina. 89 Arterial endothelium is permeable to all plasma proteins. The final concentration of these proteins in the intima is apparently dependent on the degree of retention (trapping) and rates of degradation and efflux. 90 Transcytosis and passage through intercellular junctions are both probable pathways for the transport of macromolecules across the endothelium. 91 The rates of transport of lipoproteins and other macromolecules across the endothelium appear to be dependent on the plasma concentration and on the size and charge of the particles or proteins 92 as well as on the location along the arterial tree and the age, blood pressure, and vascular tone of the individual. 9394 Under normal conditions, the endothelium does not support the adherence of platelets or the formation of thrombi. This thromboresistant property appears to be dependent on the endothelial cell membrane content of thrombomodulin and its ability to bind thrombin. 95 The thrombomodulin-thrombin complex in turn activates protein C, which complexes with protein S and inactivates coagulation factor Va. 96 In addition, endothelial cells may derive thromboresistance from their ability to metabolize the platelet aggregating agents adenosine diphosphate, serotonin, angiotensin, and prostaglandin F, and to synthesize and secrete plasminogen activator 97 and prostacyclin.
-98
The normal arterial endothelium also does not support the adherence of large numbers of leukocytes. However, in vitro studies have shown that upon activation of endothelial cells from human umbilical veins with cytokines, such as interleukin-1 and tumor necrosis factor, or oxidized LDL, there is a large increase in leukocyte adherence that may be due to the expression of leukocyte-specific adherence molecules. These are referred to as endothelial-leukocyte adhesion molecules and intercellular adhesion molecules, which are specific for monocytes/neutrophils and lymphocytes respectively.
99-101 Endothelial cells from large arteries of hypercholesterolemic rabbits express monocyte-specific endothelial-leukocyte adhesion molecules.
102 Endothelial cells can express chemotactic proteins, 103104 hematopoietic factors, 105 and major histocompatibility antigens.
106
Normal endothelial cells may be extremely important in regulating vascular tone and contraction. 107 Human and porcine aortic endothelial cells and smooth muscle cells synthesize and secrete prostacyclin, which prevents platelet aggregation and causes vascular relaxation by its capacity to stimulate the production of cAMP.
108
-109 Endothelial cells also secrete another potent vasoactive agent called endothelium-derived relaxing factor.
110 Through a mechanism that at least in part includes nitric oxide, endothelium-derived relaxing factor stimulates vascular smooth muscle cell production of cGMP and phosphorylation of several proteins involved in cellular contractility.
111 Endothelial cells may also stimulate vasoconstriction. A peptide of 21 amino acids has been isolated from cultured porcine aortic endothelial cells and shown to be an extremely potent vasoconstrictor. This peptide, called endothelin, stimulates vasoconstriction by activating voltage-dependent calcium channels in vascular smooth muscle cells.
112
The main properties of endothelial cells are summarized in Table 1 . For more complete discussions of specific topics on endothelium, the reader is directed to recent reviews. (Figures 3 and 4) occur in the proteoglycan-rich (upper) intimal layer. Rough endoplasmic reticulum-rich smooth muscle cells contain few myofilaments, and sometimes none are visible. Although there is more rough endoplasmic reticulum than there are myofilaments, rough endoplasmic reticulum does not fill the cytoplasm, and much of the cytoplasm consists of an electron-microscopically nondescript matrix. In cell culture, rough endoplasmic reticulum-rich smooth muscle cells can synthesize a wide variety of intercellular matrix components. 121 When studied by immunocytochemistry, rough endoplasmic reticulum-rich smooth muscle subtypes differ in cytoplasmic fiber proteins.
-123
Further support for the synthetic role of rough endoplasmic reticulum-rich smooth muscle cells derives from tissue culture experiments in which arterial smooth muscle cells are subjected to cyclic stretching. In such cells collagen synthesis is markedly increased compared with stationary cells 124 as the cells are altered from the myofilament-rich to the rough endoplasmic reticulum-rich morphology.
125
In normal human, 1 nonhuman primate, 126 pig, 41 and rabbit 38 intima, the proportion of rough endoplasmic reticulum-rich smooth muscle cells is greatest in the subendothelial portions of the proteoglycan-rich intima layer. In rats, smooth muscle cells in the eccentric intimal thickenings at arterial branch points were identical to smooth muscle cells elsewhere in the arterial wall.
127
The precise age at which smooth muscle cells appear in the intima has not been determined, but smooth muscle cells were described by Thoma 14 
A progressive increase in the degree of intimal thickness has been described in the postnatal period 16, 21, 29, 128 n i s unknown whether this is caused by intramural division of cells or by migration of medial smooth muscle cells into the intima. Radioautographic studies with tritiated thymidine, conducted primarily in rabbits, 130 At present there is no proof, however, that this phenomenon represents transmigration of medial smooth muscle cells into the intima, although migration of smooth muscle cells clearly can occur under certain conditions. 131 An increase in the number of smooth muscle cells in the developing intima by mitosis could be a response to growth regulatory molecules such as growth factors. To date, there is no information about the expression of growth factors or their accompanying receptors by normal intimal smooth muscle cells in either humans or animals. However, there is evidence that platelet-derived growth factor, platelet-derived growth factor receptors, and insulinlike growth factor-1 are expressed by smooth muscle cells from normal rat aorta. 132 Smooth muscle cells can remove deposited lipoproteins by expression of LDL receptors, phagocytosis, or both. 133134 The presence of autophagosomes in some smooth muscle cells and of small quantities of cell debris in the extracellular matrix of arterial intima (and media) have been reported in unmanipulated and apparently healthy rhesus monkeys, 135 rabbits, 38 and rats. 136137 Evidence of smooth muscle cell damage or death has not been reported for undiseased human arterial intima but, based on the animal evidence, it can be assumed to occur. The main functional properties of smooth muscle cells in the arterial intima are summarized in Table 2 . For detailed information on recent developments in arterial smooth muscle research, the reader is referred to recent reviews. 119138139 
Macrophages
Macrophages appear in the normal arterial intima as isolated cells at distant and irregular intervals. They have been seen in undiseased intima of rats, 67 ' 136 ' 140 rabbits, 141 pigs, 142 and humans. 1 ' 143 Some authors have described the cells as monocytoid or monocyte-like or as mononuclear leukocytes. Normal human coronary arteries contain isolated macrophages in the part of the intima adjacent to the endothelium from the first week of life. 1 The number of macrophages increases with age (adjusted for increase in artery size) until their number stabilizes in young adults at about two and a half times that in infants. 62 Eccentric intimal thickenings contain three times as many intimal macrophages as the opposite wall of the artery without eccentric thickening.
The presence of macrophages in arterial intima is consistent with the presence of macrophages in many other normal tissues. 144 The functions of macrophages depend on the nature of their environment. 144 - 146 There is speculation about the functions macrophages are required to perform in normal arterial intima. The functions of macrophages are summarized in Table 3 . For extensive discussions of macrophage functions in host defense, the immune response, and lipid metabolism, the reader is referred to recent reviews. 
Matrix of Arterial Intima General Comments
The extracellular matrix is a major component of normal arterial intima, particularly in areas of intima] thickening. It constitutes up to 60% of the volume of the intima. The matrix is important as the medium through which essential nutrients are transported across the intima, the site for accumulation of products elaborated by the various intimal cells, the site for accumulation of cell debris, and the avenue for migration of cells entering and traversing the intima.
Because the intima can consist of variable amounts of smooth muscle cells while the number of endothelial cells remains about the same, its extracellular matrix will consist of differing proportions of the matrix products secreted by the two cell types.
Proteoglycans
Proteoglycan molecules, because of their large physical size, concentration, and ionic properties, function in arterial permeability, filtration, ion exchange, transport and deposition of plasma materials, and regulation of cellular metabolism.
The nature, identity, and precise localization of proteoglycan types in the normal human intima has not been resolved. Ruthenium red staining of pig and rabbit aortas indicate that the subendothelial space contains large chondroitin sulfate proteoglycans that may or may not be similar to the chondroitin sulfate proteoglycan in the intercellular space of the media. 3162 There is increased proteoglycan 163 in normal human arterial intima containing several smooth muscle cell layers (intimal thickening). In normal human coronary arteries, the contents of dermatan sulfate and chondroitin sulfate increase with age. 169 Based on topographical distribution of proteoglycan types in normal human aortic media, Volker et al 170 described dermatan sulfate proteoglycan associated with collagen fibers, heparan sulfate proteoglycan associated with elastic fibers as well as the surfaces of smooth muscle cells, and chondroitin sulfate proteoglycan in the extracellular space.
Collagens
Collagen plays a role in the attachment of endothelial cells to the subendothelial matrix, thus contributing to endothelial cell integrity. The family of collagen molecules consists of at least two or more genetically distinct protein types. Based on current studies, there are at least 18 genes to code for the constituent alpha chains. 171 - 174 The major types in the artery wall are the two interstitial collagens, types I and III.
Gay et al 175 demonstrated immunologically, in the aorta of a 4-year-old child, that type III collagen was localized in the subendothelial space of the intima. Type I collagen was not detected in this location. Type III collagen localized in the subendothelial space of arteries of young persons may be synthesized by the endothelium, because bovine endothelial cells in culture can synthesize this collagen type.
176177
With aging, there is a change in the intimal ratio of types I and III collagen in favor of type I. Increased amounts of type I may reflect the metabolic properties of an increased number of smooth muscle cells present in the intima, because smooth muscle cells in culture synthesize both type I and type III collagen. 178 Studies of human aorta intima-media, including the arch, the thoracic and abdominal aortas, and the carotid artery, have consistently indicated type I collagen as the major type. 178 - 181 The presence of other collagen types has been described in human arteries but in smaller amounts than types I and III. These include types IV, V, and VI, which collectively compose only about 0.5-1.0% of the total arterial collagen. Type V collagen is a pericellular collagen and may bind interstitial collagen to cells or basal laminae. This collagen has been localized immunologically in close association with the endothelial cells and the basal lamina of the smooth muscle cells and in the subendothelial basement membrane. 182 189 have been shown to synthesize type IV collagen. Type VI, or "short-chain," collagen has been isolated from human aortic intima 190 and is thought to serve as a link between collagenous and noncollagenous structures. 191 
Elastin
By electron microscopy, 192 " 194 the elastic fibers of the media include two distinguishable components: an amorphous component, elastin, which does not possess any regular repeating structure or banding pattern, and a microfibrillar component. In the musculoelastic layer of intima, and particularly in eccentric intimal thickening, elastic fibers are prominent and mimic those of the media. With increasing age there is a decrease in the elastin content (relative to collagen) in the entire grossly normal human aorta. 195 The precursor to the elastin component of the elastic fiber is tropoelastin, which is secreted from cells as a protein with a molecular weight of 72,000.
196 - 200 Both smooth muscle cells 121 - 201 -202 and endothelial cells 203 -204 have been reported to synthesize elastin.
Fibronectin and Laminin
Other components such as fibronectin and laminin are also present in the extracellular matrix of normal intima. 205 Fibronectin is a high-molecular-weight, multifunctional, ubiquitous, adhesive glycoprotein found on cell surfaces, in extracellular matrixes, and in blood. The molecule functions in cell-cell adhesion and cell-substrate adhesion, cell motility, and specific binding of molecules through specialized domains in the molecule. Most notable are the collagen-binding domain, the heparin-binding domain, and the cell membrane-binding domain, through which cell-matrix interactions occur. Laminin, another major noncollagenous glycoprotein, along with heparan sulfate proteoglycan and type IV collagen, is a major component of the basement membrane underlying the endothelium. In vitro stud-
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ies have demonstrated that laminin accelerates the attachment of endothelial cells to type IV collagen but not to other collagen types.
Plasma Components
Saline extracts of human aortic intima have been examined and in general show protein content (polyacrylamide gel electrophoretic patterns) very similar to those of plasma proteins. 206 Soluble proteins extracted from grossly normal aortic intima with neutral buffered saline contain immunoglobulin A, immunoglobulin G, a trace of immunoglobulin M, c3-complement component, a,-antitrypsin, a 2 -macroglobulin, fibrinogen, albumin, LDL, HDL, a, acid glycoprotein, j3 2 -glycoprotein, transferrin, and ceruloplasmin. 207 In studies using nonionic detergents to isolate soluble proteins from human thoracic aortic intimas without visible atherosclerosis, major proteins identified were actin, tropomyosin-like proteins, and glycoproteins with molecular weights of 35,000 and 30,000, each consisting of more than one component differing in relative charge. 206 Several proteins apparently originating from plasma were identified, including albumin, immunoglobulin G, a { antitrypsin, transferrin, haptoglobin /3-chain, apo A-I, apo A-II, fibrinogen /3-chain, a 2 heparan sulfate glycoprotein, and an a r antichymotrypsin.
Concentrations of the plasma proteins in normal human intima have been measured by electrophoresis directly from the tissue into antibody-containing gels.
207
- 208 For some cases the concentrations of LDL in intima were similar to, or higher than, the concentration of plasma LDL. For some proteins such as albumin, intimal concentrations were significantly lower than plasma concentrations. LDL concentration in lesion-free intima has been positively correlated with an individual's plasma lipid level. 208 It appears that all plasma proteins are present in the intima in concentrations directly related to the protein's molecular weight and to the plasma concentration. 209 " 211 In the normal artery, LDL is localized in the intima and is usually not detectable in the underlying inner media. 211 Lipoproteins are increased in eccentric intimal thickening compared with adjacent areas without eccentric thickening in the human abdominal aorta. 8 Normal intima contains soluble fibrinogen as well as fibrinogen cleavage products, suggesting that in addition to flux of fibrinogen in normal artery, there is continuous conversion of fibrinogen to fibrin and lysis of fibrin within the intima. 212 Fibrinogen/fibrin-1 was detected with a specific monoclonal antibody in two of 12 specimens of grossly normal human aortas. Reduced heart attack incidence up to 62%* -in Helsinki HeartStudy patients whose baseline HDL was <35 mg/dL and median baseline LDL was 186 mg/dL. 1 Incidence of serious coronary events was similar for LOPID and placebo subgroups with baseline HDL above the median (46.4 mg/dL).'
Raised low HDL 25% -in these Helskinki Heart Study patients.
RAISES HDL, LOWERS LDL AND TRIGLYCERIDES DRAMATICALLY REDUCES HEART ATTACK
Contraindicated in patients with hepatic or severe renal dysfunction, including primary biliary cirrhosis, preexisting gallbladder disease, or hypersensitivity togemfibrozil. LOPID may increase cholesterol secretion into the bile, leading to cholelithiasis. Caution should be exercised when anticoagulants are given in conjunction with LOPID.
[gemfibrozil)
Lopid' (Gemfibrozil Capsules and Tablets) Before prescribing, please tee full prescribing Information. A Brief Summary follow*. CONTRAINDICATIONS. 1 Hepatic Of severe renal dysfunction including primary biliary cirrhosis 2 Preexisting gallbladder disease (See WARNINGS) 3 Hypersensitivity to gemfibrozil WARNINGS. 1 Because of chemical, pharmacological, and clinical similarities between gemfibrozil and clofibrate, the adverse findings with clofibrate in two large clinical studies may also apply to gemfibrozil In the first ol those studies the Coronary Drug Project, 1000 subjects with previous myocardial infarction were treated for five years with clofibrate There was no difference in mortality between the clofibrate-treated subtects and 3000 placebo-treated subjects, but twice as many clofibrate-treated subjects developed cholelithiasis and cholecystitis requiring surgery In (he other study, conducted by the World Health Organization (WHO), 5000 subjects without known coronary heart disease were treated with clofibrate for five years and followed one year beyond There was a statistically significant, 29% higher total mortality in the clofibratetreated than in a comparable placebo-treated control group The excess mortality was due to a 33% increase in noncardiovascular causes, including malignancy, postcholecystectomy complications, and pancreatitis The higher risk of clofibrate-treated subjects for gallbladder disease was confirmed During the Helsinki Heart Study and in the 1W year follow-up period since the trial was completed, mortality from any cause was 59 (2 9%) in the Lopid group and 55 (2 7%) in the placebo group Mortality from any cause during the double-Wind portion of the study was 44 deaths in the Lopid group and 43 in the placebo group Because of the more limited size of the Helsinki Heart Study, this result is not statisticallysigmficantly different from the 29% excess mortality seen in the clofibrate group in the separate WHO study Noncoronary heart disease related mortality showed a 58% greater trend in the Lopid group (43 vs 27 patients in the placebo group p-0056)
In the Helsinki Heart Study, the incidence of total malignancies discovered during the trial and in the 1'/; years since the trial was completed was 39 in the Lopid group and 29 in the placebo group (difference not statistically significant) This includes 5 basal cell carcinomas in the Lopid group and none in the placebo group (p«006, historical data predicted an expected 4 7 cases in the placebo group) Gl malignancies and deaths from malignancies were not statistically different between Lopid and placebo subgroups Follow-up of the Helsinki Heart Study participants will provide further information on cause-specific mortality and cancer morbidity 2 A gallstone prevalence substudy of 450 Helsinki Heart Study participants showed a trend toward a greater prevalence of gallstones during the study within the Lopid treatment group (7 5% vs 4 9% for the placebo group, a 55% excess for the gemfibrozil group) A trend toward a greater incidence of gallbladder surgery was observed for the Lopid group (17 vs 11 subjects a 54% excess) This result did not differ statistically from the increased incidence of cholecystectomy observed in the WHO study in the group treated with clofibrate Both clofibrate and gemfibrozil may increase cholesterol excretion into the bile leading to cholelithiasis If cholelithiasis is suspected, gallbladder studies are indicated Lopid therapy should be discontinued if gallstones are found 3 Since a reduction of mortality from coronary artery disease has not been demonstrated and because liver and interstitial cell testicular tumors were increased in rats, Lopid should be administered only to those patients descnbed in the INDICATIONS AND USAGE section If a significant serum lipid response is not obtained, Lopid should be discontinued 4 Concomitant Anticoagulants-Caution should be exercised when anticoagulants are given in conjunction with Lopid The dosage of the anticoagulant should be reduced to maintain the prothrombin time at the desired level to prevent bleeding complications Frequent prothrombin determinations are advisable until it has been definitely determined that the prothrombin level has stabilized 5 Concomitant therapy with Lopid and Mevacor* (lovastatin) has been associated with rhabdomyolysis, markedly elevated creatine kinase (CK) levels and myoglobinuria, leading in a high proportion of cases to acute renal failure In most subjects who have had an unsatisfactory liptd response to either drug alone, the possible benefit of combined therapy with lovastatin and gemfibrozil does not outweigh the risks of severe myopathy, rhabdomyolysis, and acute renal failure (See Drug Interactions) The use of fibrates alone, including Lopid, may occasionally be associated with myositis Patients receiving Loptd and complaining of muscle pain, tenderness, or weakness should have prompt medical evaluation for myositis, including serum creatine kinase level determination If myositis is suspected or diagnosed, Lopid therapy should be withdrawn 6 Cataracts-Subcapsular bilateral cataracts occurred in 10%. and unilateral in 6 3 % of male rats treated with gemfibrozil at 10 times the human dose. PRECAUTIONS. 1 Initial Therapy -Laboratory studies should be done to ascertain that the LIPID levels are consistently abnormal Before instituting Lopid therapy, every attempt should be made to control serum lipids with appropriate diet, exercise, weight loss in obese patients, and control of any medical problems such as diabetes mellitus and hypothyroidtsm that are contributing to the lipid abnormalities 2 Continued Therapy-Periodic determination of serum lipids should be obtained, and the drug withdrawn if lipid response is inadequate after 3 months of therapy 3 Drug Interaction*-(A) Lovastatin: Rhabdomyolysis has occurred with combined gemfibrozil and lovastatin therapy It may be seen as early as 3 weeks after initiation of combined therapy or after several months In most subjects who have had an unsatisfactory lipid response to either drug alona the possible benefit of combined therapy with lovastatin and gemfibrozil does not outweigh the risks of severe myopathy, rhabdomyolysis. and acute renal failure There is no assurance that periodic monitoring of creatine kinase will prevent the occurrence of severe myopathy and kidney damage (B) Anticoagulants: CAUTION SHOULD BE EXERCISED WHEN ANTICOAGU-LANTS ARE GIVEN IN CONJUNCTION WITH LOPID THE DOSAGE OF THE ANTI-COAGULANT SHOULD BE REDUCED TO MAINTAIN THE PROTHROMBIN TIME AT  THE DESIRED LEVEL TO PREVENT BLEEDING COMPLICATIONS FREQUENT  PROTHROMBIN DETERMINATIONS ARE ADVISABLE UNTIL IT HAS BEEN  DEFINITELY DETERMINED THAT THE PROTHROMBIN LEVEL HAS STABILIZED 4 Cardnogenesls, Mutagenesls, Impairment of Fertility-Long-term studies have been conducted in rats and mice at one and ten times the human dose The incidence ot benign liver nodules and liver carcinomas was significantly increased in high dose male rats The incidence of liver carcinomas increased also in low dose males, but this increase was not statistically significant (p-01) In high dose female rats, there was a significant increase in the combined incidence of benign, and malignant liver neoplasms In male and female mice, there were no statistically significant differences
BID RAISES HDL, LOWERS LDL AND TRIGLYCERIDES DRAMATICALLY REDUCES HEART ATTACK
Lopld* (Gemlibrozil Capsules and Tablets) from controls in the incidence o( liver tumors, but the doses tested were lower than those shown to be carcinogenic with other fibrates Male rats had a dose-related and statistically significant increase of benign Leydig cell tumors at 1 and 10 times the human dose Electron microscopy studies have demonstrated a flond hepatic peroxisome proliferation following Lopid administration to the male rat An adequate study to test for peroxisome proliferation has not been done in humans but changes in peroxisome morphology have been observed Peroxisome proliferation has been shown to occur in humans with either of two other drugs of the fibrate class when liver biopsies were compared before and after treatment in the same individual Administration of approximately three or ten times the human dose to male rats for 10 weeks resulted in a dose-related decrease of fertility Subsequent studies demonstrated that this effect was reversed after a drug-free period of about eight weeks, and it was not transmitted to the offspring 5 Pregnancy Category B-Reproduction studies have been performed in the rat at doses 3 and 9 times the human dosa and in the rabbit at 2 and 6 7 times the human dose These studies have revealed no evidence of impaired fertility in females or harm to the fetus due to Lopid Minor fetotoxicity was manifested by reduced birth rates observed at the high dose levels No significant malformations were found among almost 400 offspring from 36 litters of rats and 100 fetuses from 22 litters of rabbits There are no studies in pregnant women In view of the fact that Lopid is tumongenic in male and female rats, the use of Lopid in pregnancy should be reserved for those patients where the benefit clearly outweighs the possible risk to the patient or fetus 6 Nursing Mothers-Because of the potential for tumongenicrty shown for gemfibrozil in rats, a decision should be made whether lo discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother 7 Hematologlc Changes-Mild hemoglobin, hematocrit and white blood cell decreases have been observed in occasional patients following initiation of Lopid therapy However, these levels stabilize during long-term administration Rarely, severe anemia, leukopenia, thrombocytopenia, and bone marrow hypoolasia have been reported Therefore, periodic Wood counts are recommended dunng the first 12 months of Lopid administration 8 Liver Function-Abnormal liver function tests have been observed occasionally during Lopid administration, including elevations ol AST (SGOT), ALT (SGPT). LDH, txl irutxn, and alkaline phosphatasa These are usually reversible when Lopid is discontinued Therefore periodic liver function studies are recommended and Lopid therapy should be terminated if abnormalities persist 9 Use In Children-Safety and efficacy in children have not been established ADVERSE REACTIONS. In the double-blind controlled phase of the Helsinki Heart Study, 2046 patients received Lopid for up to 5 years In that study, the following adverse reactions were statistically more frequent in subjects in the Lopid group (placebo incidence in parentheses) gastrointestinal reactions, 34 2 %
